The FDA also expanded the use of Advair Diskus 250/50 to a broader patient population which includes not only patients with COPD associated with chronic bronchitis, but also emphysema or both ...

GSK would continue to make Advair inhalers in Zebulon if generic competition emerges this year. It also makes new asthma inhalers and two HIV drugs at its Zebulon facility. Chris Seward ...

The letter concludes discussions between GSK and the agency following FDA advisory committee meetings regarding the safety profile of long-acting beta2-agonists in the treatment of asthma, including ...

RESEARCH TRIANGLE PARK, N.C., Aug. 8 -- GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the supplemental drug application for ...

Even after going off patent in some markets, GlaxoSmithKline's Advair looked like the gift that would keep on giving. Its sophisticated inhaler device made it difficult to copy, protecting sales of ...